Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Brain Pathology (Zurich, Switzerland)|January 11, 2016
Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's DiseaseKim-Ann Saal, Dagmar Galter, Sigrun Roeber, et al.Scientific Reports|April 3, 2023
Heat denaturation enables multicolor X10-STED microscopyKim Ann Saal, Ali H Shaib, Nikolaos Mougios, et al.Pharmacology & Therapeutics|April 6, 2018
ROCK inhibition in models of neurodegeneration and its potential for clinical translationJan Christoph Koch, Lars Tatenhorst, Anna-Elisa Roser, et al.Journal of Neuropathology and Experimental Neurology|July 9, 2014
Rho kinase inhibition by fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson diseaseLars Tatenhorst, Lars Tönges, Kim-Ann Saal, et al.Frontiers in Neuroscience|October 24, 2014
The rho kinase inhibitor Y-27632 improves motor performance in male SOD1(G93A) miceRené Günther, Kim-Ann Saal, Martin Suhr, et al.Angewandte Chemie (International Ed. in English)|January 8, 2019
Boron-Containing Probes for Non-optical High-Resolution Imaging of Biological SamplesSelda Kabatas, Paola Agüi-Gonzalez, Kim-Ann Saal, et al.Journal of Neurochemistry|December 20, 2020
Rho-kinase inhibition by fasudil modulates pre-synaptic vesicle dynamicsKim Ann Saal, Carmina Warth Pérez Arias, Anna-Elisa Roser, et al.Neurobiology of Disease|October 7, 2014
AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivoKim-Ann Saal, Jan C Koch, Lars Tatenhorst, et al.Frontiers in Aging Neuroscience|October 14, 2014
Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's diseaseLars Tönges, Eva M Szegö, Patrizia Hause, et al.Glia|December 7, 2013
Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosisLars Tönges, Rene Günther, Martin Suhr, et al.Pageof 2